# Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

> **NCT03017573** · NA · RECRUITING · sponsor: **Institut Curie** · enrollment: 1050 (estimated)

## Conditions studied

- Ovarian Cancer
- Triple-Negative Breast Cancer
- Head and Neck Cancer
- Cervical Cancer
- Sarcoma
- Vulva Cancer

## Interventions

- **PROCEDURE:** Tumor biopsies / Tumor surgery
- **PROCEDURE:** Blood withdrawal

## Key facts

- **NCT ID:** NCT03017573
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-01-06
- **Primary completion:** 2029-08-06
- **Final completion:** 2032-01-06
- **Target enrollment:** 1050 (ESTIMATED)
- **Last updated:** 2026-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03017573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03017573, "Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03017573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*